Vnitr Lek 2013, 59(3):194-200

Treatment of diabetic macular oedema

J. Ernest
Oční klinika 1. lékařské fakulty UK a ÚVN Praha, přednosta doc. MUDr. Jiří Pašta, CSc., FEBO

Diabetic macular oedema (DMO) is currently the main complication associated with diabetes. The percentage of patients with DMO grows alongside the increasing number of diabetes occurrences. The DMO treatment has seen major developments in the past few years. A number of new treatment technologies have emerged, which enable not only a stabilisation of macular oedema but in the case of an early detection also a decrease of retina oedema accompanied by a visual functions improvement. Laser coagulation has remained the standard DMO treatment for many years; when applying modern diagnostic testing technologies (FAG and OCT), the newest trend in DMO treatment is the use of anti-VEGF preparations, depot intravitreal corticoids and in some cases also surgical intervention in the form of pars plana vitrectomy (PPV). The DMO treatment algorithm is presented in this paper.

Keywords: diabetic macular oedema (DMO, DME); anti-VEGF; pars plana vitrectomy (PPV); depot corticoids; laser coagulation

Received: January 27, 2013; Published: March 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ernest J. Treatment of diabetic macular oedema. Vnitr Lek. 2013;59(3):194-200.
Download citation

References

  1. Boyer DS, Faber D, Gupta S et al. Ozurdex CHAMPLAIN Study Group. Dexamethazon intravitreal implant for treatment of diabetic macular edema in vitrectomized pacients. Retina 2011: 4 (Epub ahead of print). Go to original source...
  2. DRCR Network, Browning DJ, Glassman AR et al. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Opthalmology 2007; 114: 525-536. Go to original source... Go to PubMed...
  3. DRCR Network. Factors asscociated with visual acuity outcomes after vitrectomy for diabetic macular edema. Retina 2010; 30: 1488-1495. Go to original source... Go to PubMed...
  4. Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical quidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 2. Opthalmology 1987; 94: 761-774. Go to original source... Go to PubMed...
  5. Figuera J, Khan J, Nunes N et al. Prospective randomized controlled trial comparing sub-threshold diode laser photocoagulation and conventional green laser for clinically significant macula edema. Br J Opthalmol 2009; 93: 1341-1344. Go to original source... Go to PubMed...
  6. Hikichi T, Fujio N, Akiba J et al. Association between the short-term natural history of diabetic macular edema and vitreomacular relationship in the II diabetes mellitus. Opthalmology 1997; 104: 473-478. Go to original source... Go to PubMed...
  7. Chew EY, Klein ML, Ferris FL et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Opthalmol 1996; 114: 1079-1084. Go to original source... Go to PubMed...
  8. Kampik A. Vitrectomy a viable option in select DME cases. Ocular surgery news 2012; 2: 22.
  9. Murphy R. Therapeutic triangulation: The DME treatment revolution. Retinal physician 2012; 4: 54-57.
  10. Nasrallah FP, Jalkh EA, Van Copenolle F et al. The role of the vitreous in diabetic macular edema. Opthalmology 1988; 95: 1335-1339. Go to original source... Go to PubMed...
  11. Nguyen QD, Brown DM, Marcus DM et al. Ranibizumab for diabetic macular edema: result from 2 phase III randomized trials: RISE and RIDE. Opthalmology 2012; 119: 1064-1073. Go to original source... Go to PubMed...
  12. Park JH, Woo SJ, Ho YJ et al. Effect of vitrectomy on microcirculation in patients with diffuse macular edema. Graefes Arch Clin Exp Opthalmol 2009; 217: 1009-1017. Go to original source... Go to PubMed...
  13. The READ-2 Study Group. Two-year outcomes of ranibizumab for edema of the macula in diabetes (READ-2) study. Opthalmology 2010; 117: 2146-2151. Go to original source... Go to PubMed...
  14. The RESTORE Study Group. Ranibizumab monoteraphy or combined with laser monotherapy for diabetic macular edema. Opthalmology 2011; 118: 615-625.
  15. UK Prospective Study Group. UKPDS38. Tight blood pressure control and risk of macrovascular and microvascular complication in type 2 diabetes mellitus. BMJ 1998; 317: 703-713. Go to original source... Go to PubMed...
  16. Virgil G, Manchini F, Diamastrogiovanni AF et al. Optical coherence tomography versus stereoscopic fundus photography or biomicroscophy for diagnostic macular edema. Inv. Opthalmol Vis Sci 2007; 48: 4963-4973. Go to original source... Go to PubMed...
  17. Vujosevic S, Bottega E, Casciano M et al. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. Retina 2010; 30: 908-916. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.